BioCardia, Inc.
BCDA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000925741
In the last 90 days, BioCardia, Inc. insiders filed 9 open-market purchases and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in BioCardia, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 10
- −12 vs. Q1 2024
- Shares held
- 86.6K
- −43.1K (−33.2%) vs. Q1 2024Converted for a 1-for-15 split
- Total value
- $227.8K
- −$563.0K (−71.2%) vs. Q1 2024
- New holders
- 1
- 5 more added
- Sold out
- 13
- 1 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCDA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $1.65M |
| Q1 2026 | 18 | $831.1K |
| Q4 2025 | 20 | $812.3K |
| Q3 2025 | 18 | $551.9K |
| Q2 2025 | 16 | $593.2K |
| Q1 2025 | 12 | $623.8K |
| Q4 2024 | 13 | $272.2K |
| Q3 2024 | 9 | $316.6K |
| Q2 2024 | 10 | $227.8K |
| Q1 2024 | 22 | $790.8K |
| Q4 2023 | 24 | $1.37M |
| Q3 2023 | 16 | $709.6K |
| Q2 2023 | 23 | $4.43M |
| Q1 2023 | 23 | $4.09M |
| Q4 2022 | 25 | $4.87M |
| Q3 2022 | 23 | $3.17M |
| Q2 2022 | 26 | $3.10M |
| Q1 2022 | 24 | $5.49M |
| Q4 2021 | 23 | $5.78M |
| Q3 2021 | 22 | $9.01M |
| Q2 2021 | 20 | $12.3M |
| Q1 2021 | 19 | $13.5M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding BioCardia, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Susquehanna International Group, LLP | 44,557 | $132.3K | 0.00% | +44,557 | New |
| Geode Capital Management, LLC | 13,021 | $38.7K | 0.00% | +2,630+25.3% | AddedConverted for a 1-for-15 split |
| Vanguard Group Inc | 12,884 | $38.3K | 0.00% | −30,500−70.3% | ReducedConverted for a 1-for-15 split |
| Tower Research Capital LLC (TRC) | 3,036 | $9.02K | 0.00% | +3,015+14,543.1% | AddedConverted for a 1-for-15 split |
| Advisor Group Holdings, Inc. | 11,189 | $3.80K | 0.00% | +9,764+685.3% | AddedConverted for a 1-for-15 split |
| Pingora Partners LLC | 1,036 | $3.08K | 0.00% | 00.0% | UnchangedConverted for a 1-for-15 split |
| Bank of America Corp | 444 | $1.32K | 0.00% | +9+2.0% | AddedConverted for a 1-for-15 split |
| Global Retirement Partners, LLC | 411 | $1.22K | 0.00% | 00.0% | UnchangedConverted for a 1-for-15 split |
| Morgan Stanley | 30 | $89 | 0.00% | 00.0% | UnchangedConverted for a 1-for-15 split |
| Royal Bank of Canada | 26 | $0 | 0.00% | +18+245.1% | AddedConverted for a 1-for-15 split |
| CM Management, LLC | 0 | $0 | 0.00% | −46,667−100.0% | Sold outConverted for a 1-for-15 split |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −7,405−100.0% | Sold outConverted for a 1-for-15 split |
| Family Management Corp | 0 | $0 | 0.00% | −5,167−100.0% | Sold outConverted for a 1-for-15 split |
| BlackRock Inc. | 0 | $0 | 0.00% | −3,059−100.0% | Sold outConverted for a 1-for-15 split |
| Brown Advisory Inc | 0 | $0 | 0.00% | −2,206−100.0% | Sold outConverted for a 1-for-15 split |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold outConverted for a 1-for-15 split |
| State Street Corp | 0 | $0 | 0.00% | −1,400−100.0% | Sold outConverted for a 1-for-15 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −1,282−100.0% | Sold outConverted for a 1-for-15 split |
| Wedbush Securities Inc | 0 | $0 | 0.00% | −1,000−100.0% | Sold outConverted for a 1-for-15 split |
| Virtu Financial LLC | 0 | $0 | 0.00% | −937−100.0% | Sold outConverted for a 1-for-15 split |
| Octavia Wealth Advisors, LLC | 0 | $0 | 0.00% | −949−100.0% | Sold outConverted for a 1-for-15 split |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −480−100.0% | Sold outConverted for a 1-for-15 split |
| Wells Fargo & Company | 0 | $0 | 0.00% | −7−100.0% | Sold outConverted for a 1-for-15 split |